Holen Sie sich die Stockscreener-App
25.62
3.09%
-0.7865
Schlusskurs vom Vortag:
$26.41
Offen:
$26.41
24-Stunden-Volumen:
433.48K
Relative Volume:
0.40
Marktkapitalisierung:
$1.93B
Einnahmen:
$122.87M
Nettoeinkommen (Verlust:
$-73.68M
KGV:
-26.14
EPS:
-0.9803
Netto-Cashflow:
$-39.27M
1W Leistung:
+1.97%
1M Leistung:
+55.50%
6M Leistung:
+105.58%
1J Leistung:
+94.79%
1-Tages-Spanne:
$25.43
$26.77
1-Wochen-Bereich:
$25.30
$27.49
52-Wochen-Spanne:
$9.03
$28.49
Zymeworks Inc. Stock (ZYME) Company Profile
Firmenname
Zymeworks Inc.
Sektor
Branche
Telefon
604-678-1388
Adresse
1385 West 8th Avenue, Suite 540, Vancouver, BC
Vergleichen Sie ZYME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
25.64 | 1.99B | 122.87M | -73.68M | -39.27M | -0.9803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.54 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.32 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.88 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
892.74 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.73 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-03 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-10-24 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-20 | Eingeleitet | TD Cowen | Buy |
| 2024-12-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-11-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-04 | Bestätigt | H.C. Wainwright | Neutral |
| 2022-12-20 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-05-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-03-15 | Eingeleitet | Evercore ISI | Outperform |
| 2021-12-10 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | Fortgesetzt | Guggenheim | Neutral |
| 2021-10-07 | Eingeleitet | Jefferies | Hold |
| 2021-03-31 | Eingeleitet | Credit Suisse | Outperform |
| 2021-02-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-01-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-08-06 | Eingeleitet | SVB Leerink | Outperform |
| 2020-01-10 | Eingeleitet | Wolfe Research | Outperform |
| 2019-12-09 | Eingeleitet | JP Morgan | Neutral |
| 2019-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-20 | Eingeleitet | Guggenheim | Buy |
| 2019-09-30 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | Eingeleitet | Stifel | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2018-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2018-03-19 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
Zymeworks Inc Stock Analysis and ForecastPrice Momentum Alerts & Low Entry Investment Plans - earlytimes.in
How higher bond yields impact Zymeworks Inc. (ZA8) stockPortfolio Update Report & Weekly Setup with ROI Potential - Newser
Is Zymeworks Inc. (ZA8) stock cheap vs fundamentalsPortfolio Value Report & Long Hold Capital Preservation Tips - Newser
What technical patterns form on Zymeworks Inc. (ZA8) stock chartsWeekly Gains Summary & Short-Term Swing Trade Alerts - Newser
Is Zymeworks Inc. (ZA8) stock considered safe havenInsider Selling & AI Powered Market Trend Analysis - Newser
Will Zymeworks Inc. (ZA8) stock maintain strong growth2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences - MSN
Citizens Initiates Coverage of Zymeworks (ZYME) with Market Outperform Recommendation - Nasdaq
How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Gainers & Verified Technical Signals - Newser
Zymeworks Announces Participation in Upcoming Conferences - The Manila Times
Zymeworks Inc. Announces Participation in ASCO GI and J.P. Morgan Healthcare Conference, Highlighting Advances in HER2-Driven Gastrointestinal Cancers and Novel Drug Developments - Quiver Quantitative
Is Zymeworks Inc. (ZA8) stock supported by strong fundamentalsAnalyst Upgrade & Accurate Intraday Trade Tips - Newser
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN
Is Zymeworks Inc a good long term investmentMarket Capitalization Trends & Join a Community of Smart Investors - earlytimes.in
Zymeworks Inc. $ZYME Stock Position Lifted by Tejara Capital Ltd - MarketBeat
Zymeworks (ZYME) Is Up 13.8% After Positive Zanidatamab Trial and Share Buyback PlanWhat's Changed - simplywall.st
Zymeworks (NASDAQ:ZYME) Stock Price Up 8%Time to Buy? - MarketBeat
Zymeworks (NYSE:ZYME) Trading Up 6.1%Here's Why - MarketBeat
Zymeworks Stock Sees Surge In Retail Chatter After Royalty Pivot, Cancer Trial Win Sparks Target Price Hikes - MSN
Zymeworks (NYSE:ZYME) Hits New 1-Year HighTime to Buy? - MarketBeat
Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript - MSN
Zymeworks to Engage in Key Investor Conferences - MSN
Zymeworks stock hits 52-week high at 26.2 USD By Investing.com - Investing.com Nigeria
Zymeworks (NYSE:ZYME) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Zymeworks (NASDAQ:ZYME) Sees Large Volume IncreaseHere's Why - MarketBeat
Zymeworks stock hits 52-week high at 26.2 USD - Investing.com
Zymeworks Inc.Common Stock (Nasdaq:ZYME) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content
Zymeworks Announces Participation in Upcoming Investor Conferences - lelezard.com
Shareholder Miller Files To Sell 118,000 Of Zymeworks Inc [ZYME] - TradingView
Hillsdale Investment Management Inc. Lowers Stake in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. Management to Participate in Upcoming Investor Conferences in Miami - Quiver Quantitative
Zymeworks (NASDAQ: ZYME) to Join Evercore, Citi 2025 Healthcare Conferences - Stock Titan
Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan - The Globe and Mail
Zymeworks Inc. (NASDAQ:ZYME) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Press Release: Zymeworks Announced Positive Phase 3 HERIZON-GEA-01 Results - Oncodaily
Zymeworks Shifts To Royalty-Driven Model From Licensed Drugs, Approves $125M Buyback Plan - Stocktwits
Shareholder Gallagher Files To Sell 105,000 Of Zymeworks Inc [ZYME] - TradingView
B. Riley Securities Reiterates Zymeworks (ZYME) Buy Recommendation - Nasdaq
Zymeworks (NASDAQ:ZYME) Shares Up 5.5%What's Next? - MarketBeat
Zymeworks (NYSE:ZYME) Stock Price Up 5.4%Here's What Happened - MarketBeat
ZYMEZymeworks BC Inc Stock Price and Quote - Finviz
Zymeworks (ZYME) Gets a Rating Reiteration and Price Target Boos - GuruFocus
Zymeworks: Adjusting My Levels After Ziihera’s Phase III Data For GEA (NASDAQ:ZYME) - Seeking Alpha
How Zymeworks Inc. (ZA8) stock behaves in tightening cyclesShare Buyback & Stock Portfolio Risk Management - newser.com
Finanzdaten der Zymeworks Inc.-Aktie (ZYME)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):